PNC Financial Services Group’s Definium Therapeutics DFTX Stock Holding History

PNC Financial Services Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Buy	7,620 +532	+8%	+$9.03K	﹤0.01%	2561
2025 Q4	$94.9K	Buy	7,088 +7,059	+24,341%	+$87.4K	﹤0.01%	2835
2025 Q3	$342	Buy	29 +12	+71%	+$112	﹤0.01%	4863
2025 Q2	$110	Buy	+17	New	+$112	﹤0.01%	4831
2022 Q4	–	Sell	-13,535	Closed	-$47K	–	4827
2022 Q3	$47K	Sell	13,535 -1	-0%	-$10	﹤0.01%	3014
2022 Q2	$130K	Buy	+13,536	New	+$171K	﹤0.01%	2401
2022 Q1	–	Sell	-160	Closed	-$3K	–	4641
2021 Q4	$3K	Hold	160	–	–	﹤0.01%	4081
2021 Q3	$5K	Hold	160	–	–	﹤0.01%	3941
2021 Q2	$8K	Buy	+160	New	+$8.4K	﹤0.01%	3768

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PNC Financial Services Group's DFTX Position: Q1 2026 in Review

PNC Financial Services Group increased its Definium Therapeutics (DFTX) stake by 7.5% in Q1 2026, buying an estimated $9.03K and bringing the position to 7,620 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

PNC Financial Services Group first reported a position in DFTX in Q2 2021 and has held it in 9 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

PNC Financial Services Group held 7,620 shares of Definium Therapeutics worth $144K as of Q1 2026.
PNC Financial Services Group bought 532 Definium Therapeutics shares in Q1 2026, an estimated $9.03K.
Definium Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2561 holding.
PNC Financial Services Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 9 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.